Corporate Banner
Satellite Banner
ADME Tox
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - September 2013


SMi - Geriatric Safe Medicines Summit

16 Sep 2013 - 17 Sep 2013 - London, UK



Bookmark and Share


Clinical research in geriatric patient populations requires the adaptation of traditional clinical procedures in research studies. A relatively new area of research, geriatric patient studies requires a collaboration between many different stakeholders within this field to identify and overcome the challenges involved in recruiting, treating and retaining study subjects. Join SMi as we look to address these issues with new and innovative thinking and approaches that are being applied to geriatric clinical studies.

KEY REASONS TO ATTEND

Discover the benefits of performing clinical trials in older people

Identify the key challenges and considerations when conducting clinical trials in older people

Address reasons for clinical trial retention difficulties

Discuss how modelling and simulation along with new patient reporting systems support clinical trials in older people

Explore new market gaps and discover new market strategy

Focus on the EMA geriatric medicines strategy

KEYNOTE SPEAKERS INCLUDE:

Solange Rohou, Director of Regulatory Affairs, AstraZeneca

Barbro Westerholm, Member of Parliament, Sweden, Liberal Party

Florian Von Raison, Global Programme Head, Novartis

Nina Barnett, Consultant Pharmacologist, Northwest London's Hospital NHS Trust

Philippe Guillet, Strategy Head, Sanofi

Michael Richardson, VP International and QPPV EU GPV&E, Bristol Myers Squibb

Eva Bredberg, Director Global Clinical Pharmacology, AstraZeneca

Anthea Tinker, Professor of Social Gerontology, Kings College London

Visit our website here: http://www.smi-online.co.uk/geriatricsummit13.asp

Alternatively, contact: Jonathan Collins on +44 (0)20 7827 6734 or email: jcollins@smi-online.co.uk

Academic & Group discounts available



Further information
Scientific News
Self-Assembling, Biomimetic Membranes May Aid Water Filtration
A synthetic membrane that self assembles and is easily produced may lead to better gas separation, water purification, drug delivery and DNA recognition, according to an international team of researchers.
Study Questions Presence in Blood of Heart-Healthy Molecules from Fish Oil Supplements
A new study from the Perelman School of Medicine at the University of Pennsylvania questions the relevance of fish oil-derived SPMs and their purported anti-inflammatory effects in humans.
New Material Opens Possibilities for Super-Long-Acting Pills
A pH-responsive polymer gel could create swallow able devices, including capsules for ultra-long drug delivery.
Long-sought Discovery Fills in Missing Details of Cell 'Switchboard'
A biomedical breakthrough reveals never-before-seen details of the human body’s cellular switchboard that regulates sensory and hormonal responses.
Tracking Breast Cancer Before it Grows
A team of scientists led by University of Saskatchewan researcher Saroj Kumar is using cutting-edge Canadian Light Source techniques to screen and treat breast cancer at its earliest changes.
Zebrafish Reveal Drugs that may Improve Bone Marrow Transplant
Compounds boost stem cell engraftment; could allow more matches for patients with cancer and blood diseases.
Teeth Reveal Lifetime Exposures to Metals, Toxins
Researchers have identified dental biomarkers to reveal links between early iron exposure and late life brain diseases.
An Innovative Algorithm to Decipher How Drugs Work Inside the Body
Researchers at Columbia University Medical Center (CUMC) have developed a computer algorithm that is helping scientists see how drugs produce pharmacological effects inside the body.
Uncovering the Spread of Bacteria in Pneumonia
Northwestern Medicine scientists have discovered the role a toxin produced by a pneumonia-causing bacterium plays in the spread of infection from the lungs to the bloodstream in hospitalized patients.
Ferring Bets on Bacteriophages to Treat Inflammatory Bowel Disease
Ferring Pharmaceuticals have annoucned that it will collaborate with Intralytix in the latest phase of its early stage development programme for a bacteriophage-based therapy for inflammatory bowel disease (IBD).
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!